Label-free real-time detection of biotinylated bovine serum albumin using a low-cost optical cavity-based biosensor.
We have developed a low-cost optical cavity-based biosensor with a differential detection method for point-of-care medical diagnostics. To experimentally demonstrate its label-free real-time biosensing capability, we performed the detection of biotinylated bovine serum albumin (BSA). Streptavidin is introduced into the optical cavity structure and immobilized on 3-aminopropyltriethoxysilane (APTES) coated surface. After rinsing out unbound streptavidin with DI water, biotinylated BSA without any labeling is introduced. A CMOS camera captures the transmitted light of two different wavelengths passing through the optical cavity sensing area in real-time.
Then, the differential values are calculated to enhance the responsivity. We successfully demonstrated the label-free real-time detection of biotinylated BSA, and the measurement results matched well with the simulation results. The limit of detection of the optical cavity-based biosensor for the biotinylated BSA detection with the sensing area of 180 μm × 180 μm is estimated to be 2.82 pM, which could be reduced further for a smaller sensing area with the tradeoff of a longer sensing time.
Biotinylated Lipid-Coated NaLnF 4 Nanoparticles: Demonstrating the Use of Lanthanide Nanoparticle-Based Reporters in Suspension and Imaging Mass Cytometry
Lanthanide nanoparticles (LnNPs) have the potential to be used as high-sensitivity mass tag reporters in mass cytometry immunoassays. For this application, however, the LnNPs must be made colloidally stable in aqueous buffers, demonstrate minimal non-specific binding to cells, and have functional groups to attach antibodies or other targeting agents. One possible approach to address these requirements is by using lipid coating to modify the surface of the LnNPs. In this work, 39 nm diameter NaYF4:Yb, Er NPs (LnNPs) were coated with a lipid formulation consisting of egg sphingomyelin, 1,2-dioleoyl-sn-glycero-3-phosphocholine, 1,2-dioleoyl-3-trimethylammonium propane, cholesterol-(polyethylene glycol-600), and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[biotinyl(polyethylene glycol)-2000].
The resulting biotinylated lipid-coated LnNPs were characterized by dynamic light scattering to determine the hydrodynamic size and stability in phosphate buffered saline, and the composition of the lipid coatings was quantified by liquid chromatography-tandem mass spectrometry. The specific and non-specific binding of the biotinylated lipid-coated LnNPs to a model system of functionalized polystyrene microbeads were then tested by both suspension and imaging mass cytometry. We found that targeted binding with minimal non-specific binding can be achieved with the lipid-coated LnNPs and that the lipid composition of the coating has an impact on the performance of the LnNPs as mass cytometry reporters. These results additionally establish the importance of quantifying the composition of lipid-coated nanomaterials to optimize them more effectively for their desired application.
Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with R-Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines
Recent achievement in anticancer therapy considers the application of repurposed drugs in optimal combinations with the use of specific carriers for their targeted delivery. As a result, new optimized medications with reduced side effects can be obtained. In this study, two known anticancer drugs, celecoxib and/or simvastatin, were conjugated covalently with PAMAM G3 dendrimer and tested in vitro against human squamous carcinoma (SCC-15-15) and glioblastoma (U-118 MG) cells, as well as normal human fibroblasts (BJ). The obtained conjugates were also substituted with biotin and R-glycidol to increase their affinity for cancer cells and were characterized with NMR spectroscopy and dynamic light scattering technique.
Conjugates furnished with two celecoxib and four simvastatin residues revealed the very high effectiveness and dramatically decreased the SCC-15 and U-118 MG cell viability at very low concentrations with IC50 equal to about 3 µM. Its action was 20-50-fold stronger than that of either drug alone or as a mixture. Combined conjugate revealed also additive action since it was 2-8-fold more effective than conjugates with either single drug. The combined conjugate revealed rather low specificity since it was also highly cytotoxic for BJ cells. Despite this, it may be concluded that biotinylated and R-glycidylated PAMAM G3 dendrimers substituted with both celecoxib and simvastatin can be considered as a new perspective anticancer agent, effective in therapy of malignant, incurable glioblastomas.
Functionalization of Magnetic Beads with Biotinylated Nanobodies for MALDI-TOF/MS-Based Quantitation of Small Analytes
Over the last two decades, the variable domains from heavy chain-only antibodies in camelids (nanobodies) have emerged as valuable immunoreagents for analytical and diagnostic applications. One prominent use of nanobodies is for the detection of small molecules due to their ease of production, resistance to solvents used in sample extraction, facile genetic manipulation, and small size. These last two properties make it possible to produce biotinylated nanobodies in vivo, which can be loaded in an orientated manner on magnetic beads covered with avidin, creating high-density immunoadsorbenpi twbch “”ts.
The method described here details the use of nanobody-based adsorbents to concentrate small molecular weight analytes for subsequent quantitative analysis by MALDI-TOF mass spectrometry. Quantitation requires the inclusion of an internal standard (IS), a compound with properties similar to those of the analyte, enabling compensation for uneven distribution during crystallization of the MALDI-TOF matrix. Since nanobody generation against small compounds requires conjugation to carrier proteins, the same conjugation chemistry can be used to synthesize the IS. By design the IS cross reacts with the capture nanobody and can be preloaded in the immunoadsorbent, facilitating quantitative detection of the target compound.
Bovine Serum Albumin Biotinylated (Biotin-BSA) | |||
BTN-BSA | Alpha Diagnostics | 5 mg | 343.2 EUR |
Bovine Serum Albumin (BSA) Monoclonal Antibody (Bovine), Biotinylated | |||
4-MAA248Bo21-Biotin | Cloud-Clone |
|
|
Biotinylated Bovine Serum Albumin (Biotin-LC-BSA) (3 biotin/BSA) | |||
7097-25 | Biovision | each | 266.4 EUR |
Biotinylated Bovine Serum Albumin (Biotin-LC-BSA) (3 biotin/BSA) | |||
7097-5 | Biovision | each | 138 EUR |
Biotinylated Bovine Serum Albumin (Biotin-LC-BSA) (5 biotin/BSA) | |||
7098-25 | Biovision | each | 279.6 EUR |
Biotinylated Bovine Serum Albumin (Biotin-LC-BSA) (5 biotin/BSA) | |||
7098-5 | Biovision | each | 144 EUR |
Biotinylated Bovine Serum Albumin (Biotin-LC-BSA) (12 biotin/BSA) | |||
7099-25 | Biovision | each | 292.8 EUR |
Biotinylated Bovine Serum Albumin (Biotin-LC-BSA) (12 biotin/BSA) | |||
7099-5 | Biovision | each | 157.2 EUR |
Bovine Serum Albumin (BSA) Monoclonal Antibody (General), Biotinylated | |||
4-MAA248Ge21-Biotin | Cloud-Clone |
|
|
Bovine Serum Albumin (BSA) Polyclonal Antibody (Pan-species), Biotinylated | |||
4-PAA248Ge01-Biotin | Cloud-Clone |
|
|
Recombinant Rat Serum albumin (Alb), Biotinylated | |||
CSB-EP001561RA-B | Cusabio | 10267 mg | Ask for price |
Serum Albumin Protein, Human, Recombinant, Biotinylated | |||
MBS8120605-002mg | MyBiosource | 0.02mg | 290 EUR |
Serum Albumin Protein, Human, Recombinant, Biotinylated | |||
MBS8120605-01mg | MyBiosource | 0.1mg | 580 EUR |
Serum Albumin Protein, Human, Recombinant, Biotinylated | |||
MBS8120605-5x01mg | MyBiosource | 5x0.1mg | 2470 EUR |
Native Bovine Albumin Protein, Biotinylated | |||
ALB-316B | Creative BioMart | 10mg | 111.2 EUR |
Biotinylated Recombinant Human Serum albumin/ALB Protein | |||
RP02559 | Abclonal | 500μg | 812.5 EUR |
Identification of selenoprotein O substrates using a biotinylated ATP analog
Selenoprotein O is one of 25 human selenoproteins that incorporate the 21st amino acid selenocysteine. Recent studies have revealed a previously undocumented mechanism of redox regulation by which SelO protects cells from oxidative damage. SelO catalyzes the covalent addition of AMP from ATP to the hydroxyl side chain of protein substrates in a post translational modification known as AMPylation. Although AMPylation was discovered over 50 years ago, methods to detect and enrich substrates are limited. Here, we describe protocols to clone, purify, and identify the substrates of bacterial SelO using a biotinylated ATP analog. Identification of SelO substrates and the functional consequences of AMPylation will illuminate the significance of this evolutionarily conserved selenoprotein.
Synthesis of biotinylated pentasaccharide structurally related to a fragment of glucomannan from Candida utilis
The polysaccharide mannan is the main surface antigen of the cell wall of Candida fungi, playing an important role in the pathogenesis of diseases caused by these mycopathogens. Mannan has a complex, comb-like structure and includes a variety of structural units, with their combination varying depending on the Candida species and strain. Glucomannan, a polysaccharide from Candida utilis, contains terminal α-d-glucose residues attached to oligomannoside side chains. This paper describes the first synthesis of a pentasaccharide structurally related to C. utilis glucomannan fragment, which is an α-(1→2)-linked tetramannoside terminated at the non-reducing end by an α-d-glucopyranosyl residue.
The pentasaccharide was obtained as a 3-aminopropyl glycoside, which made it possible to synthesize also its biotinylated derivative, suitable for various glycobiological studies. The most complicated step in the pentasaccharide synthesis was stereoselective 1,2-cis-glycosylation to attach the α-d-glucopyranosyl residue. This was accomplished using a glucosyl donor specially developed in our laboratory, the protecting groups of which provide the necessary α-stereoselectivity. The target biotinylated pentasaccharide thus obtained will be used in the future as a model antigen for the detection of immunodeterminant epitopes of Candida mannans.
Tags: assay kit definition biology cells and control biology cells bbc bitesize biology cells list biology cells notes biology cells past papers biology cells questions biology cells quiz biology cells quizlet biology cells revision biology cells revision notes gcse biology cells roots and suffix biology cells test biology cells worksheets biology cells worksheets free printable cells definition biology cells in biology culture cells after sorting facs culture cells meaning elisa assay kits enzyme assay kits gcse biology cells guard cells definition biology how can we obtain cells for a cell culture how to culture cells luminex assay kits metabolic assay kits mineral assay kits quant-ittm picogreentm dsdna assay kits ros assay kits squamous cells in urine culture stem cells definition biology tunel assay kits what are cells biology what are stem cells biology what is cells in biology